Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes | 指定難病告示番号 |
| 1 | (2)-epigallocatechin-3-gallate (egcg) | Epigallocatechin | - | - | - | 008 1件: 8 💬 |
| 2 | 20 mg ga | - | - | - | - | 013 1件: 13 💬 |
| 3 | 20mg/0.5ml ga | - | - | - | - | 013 1件: 13 💬 |
| 4 | 40 mg ga | - | - | - | - | 002 2件: 2 , 13 💬 |
| 5 | Aav1-gamma-sarcoglycan vector injection | - | - | - | - | 113 1件: 113 💬 |
| 6 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna | Agalsidase alfa | 1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
| 7 | Administration of drug (interferon-gamma 1-b) subcutaneously | - | - | - | - | 065 1件: 65 💬 |
| 8 | Adverse reactions of gammagard subcutaneously at week 12 | - | - | - | - | 065 1件: 65 💬 |
| 9 | Adverse reactions of gammagard subcutaneously at week 24 | - | - | - | - | 065 1件: 65 💬 |
| 10 | Adverse reactions of gammagard subcutaneously at week 36 | - | - | - | - | 065 1件: 65 💬 |